| Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms DE Gordon, J Hiatt, M Bouhaddou, VV Rezelj, S Ulferts, H Braberg, ... Science 370 (6521), eabe9403, 2020 | 696 | 2020 |
| SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling L Miorin, T Kehrer, MT Sanchez-Aparicio, K Zhang, P Cohen, RS Patel, ... Proceedings of the National Academy of Sciences 117 (45), 28344-28354, 2020 | 539 | 2020 |
| Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A KM White, R Rosales, S Yildiz, T Kehrer, L Miorin, E Moreno, S Jangra, ... Science 371 (6532), 926-931, 2021 | 333 | 2021 |
| Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression K Zhang, L Miorin, T Makio, I Dehghan, S Gao, Y Xie, H Zhong, M Esparza, ... Science Advances 7 (6), eabe7386, 2021 | 207 | 2021 |
| Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission A Escalera, AS Gonzalez-Reiche, S Aslam, I Mena, M Laporte, RL Pearl, ... Cell host & microbe 30 (3), 373-387. e7, 2022 | 173 | 2022 |
| Contribution of SARS-CoV-2 accessory proteins to viral pathogenicity in K18 human ACE2 transgenic mice JA Silvas, DM Vasquez, JG Park, K Chiem, A Allué-Guardia, ... Journal of Virology 95 (17), 10.1128/jvi. 00402-21, 2021 | 133 | 2021 |
| The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera R Rathnasinghe, S Jangra, A Cupic, C Martínez-Romero, LCF Mulder, ... MedRxiv, 2021 | 119 | 2021 |
| A household case evidences shorter shedding of SARS-CoV-2 in naturally infected cats compared to their human owners V Neira, B Brito, B Agüero, F Berrios, V Valdés, A Gutierrez, N Ariyama, ... Emerging Microbes & Infections 10 (1), 376-383, 2021 | 96 | 2021 |
| Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture K Bafna, K White, B Harish, R Rosales, TA Ramelot, TB Acton, E Moreno, ... Cell reports 35 (7), 2021 | 65 | 2021 |
| SARS-CoV-2 variants evolve convergent strategies to remodel the host response M Bouhaddou, AK Reuschl, BJ Polacco, LG Thorne, MR Ummadi, C Ye, ... Cell 186 (21), 4597-4614. e26, 2023 | 62 | 2023 |
| Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis T Kehrer, A Cupic, C Ye, S Yildiz, M Bouhaddou, NA Crossland, ... Cell host & microbe 31 (10), 1668-1684. e12, 2023 | 61 | 2023 |
| HIV protease cleaves the antiviral m6A reader protein YTHDF3 in the viral particle D Jurczyszak, W Zhang, SN Terry, T Kehrer, MC Bermúdez González, ... PLoS pathogens 16 (2), e1008305, 2020 | 56 | 2020 |
| Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune sera R Rathnasinghe, S Jangra, C Ye, A Cupic, G Singh, C Martínez-Romero, ... Nature Communications 13 (1), 3921, 2022 | 34 | 2022 |
| SARS-CoV-2 variants of concern have acquired mutations associated with an increased spike cleavage A Escalera, AS Gonzalez-Reiche, S Aslam, I Mena, RL Pearl, M Laporte, ... bioRxiv, 2021.08. 05.455290, 2021 | 20 | 2021 |
| Functional effects of cardiomyocyte injury in COVID-19 MM Siddiq, AT Chan, L Miorin, AS Yadaw, KG Beaumont, T Kehrer, ... Journal of Virology 96 (2), e01063-21, 2022 | 18 | 2022 |
| SARS-CoV-2 viral protein ORF3A injures renal tubules by interacting with TRIM59 to induce STAT3 activation H Cai, Y Chen, Y Feng, M Asadi, L Kaufman, K Lee, T Kehrer, L Miorin, ... Molecular Therapy 31 (3), 774-787, 2023 | 16 | 2023 |
| Global landscape of the host response to SARS-CoV-2 variants reveals viral evolutionary trajectories M Bouhaddou, AK Reuschl, BJ Polacco, LG Thorne, MR Ummadi, C Ye, ... bioRxiv, 2022.10. 19.512927, 2022 | 14 | 2022 |
| Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple Omicron subvariants JA Duty, T Kraus, H Zhou, Y Zhang, N Shaabani, S Yildiz, N Du, A Singh, ... Med 3 (10), 705-721. e11, 2022 | 13 | 2022 |
| The oral drug nitazoxanide restricts SARS-CoV-2 infection and attenuates disease pathogenesis in Syrian hamsters L Miorin, CE Mire, S Ranjbar, AJ Hume, J Huang, NA Crossland, ... bioRxiv, 2022.02. 08.479634, 2022 | 12 | 2022 |
| Interferon mediated prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine lacking non-structural protein 1 R Rathnasinghe, M Salvatore, H Zheng, S Jangra, T Kehrer, I Mena, ... Scientific Reports 11 (1), 22164, 2021 | 12 | 2021 |
